IMGN779: Phase I started

ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass.
Product: IMGN779
Business: Cancer
Molecular target:

Read the full 119 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE